Compounds for the treatment of neurodegenerative disorders
US7253195B2 · kind B2 · utility
12Cited by
1References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 20, 2004 |
| Grant date | Aug 7, 2007 |
| Priority date | — |
| Expiry date | Oct 27, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of the Formulawherein R3, R5, R7, U, X, Y and Z are as defined. Compounds of the Formula I have activity inhibiting production of Aβ-peptide. This invention also relates to pharmaceutical compositions and methods of treating diseases, for example, neurodegenerative diseases, e.g., Alzheimer's disease, in a mammal comprising compounds of the Formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.